Pages that link to "Q34703616"

The following pages link to Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer (Q34703616):

Displaying 29 items.

• Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma (Q33509292) (← links)
• Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo (Q33653210) (← links)
• Novel translational strategies in colorectal cancer research (Q34382804) (← links)
• Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies (Q34511615) (← links)
• Archaeosome Adjuvant Overcomes Tolerance to Tumor‐Associated Melanoma Antigens Inducing Protective CD8 T Cell Responses (Q34557185) (← links)
• Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment (Q34757266) (← links)
• A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth (Q36038477) (← links)
• Synergy of IL-21 and IL-15 in regulating CD8 T cell expansion and function. (Q36402501) (← links)
• Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice (Q36403509) (← links)
• Clinical opportunities in combining immunotherapy with radiation therapy (Q36449873) (← links)
• Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses. (Q36642808) (← links)
• "It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer. (Q37248131) (← links)
• Immunotherapy for advanced melanoma. (Q37301008) (← links)
• Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma (Q37375286) (← links)
• Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy (Q37734194) (← links)
• Systemic therapy for advanced hepatocellular carcinoma: past, present, and future (Q37734197) (← links)
• The confluence of stereotactic ablative radiotherapy and tumor immunology (Q37967688) (← links)
• The promise of combining radiation therapy and immunotherapy: morbidity and toxicity (Q39071019) (← links)
• MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR. (Q39290133) (← links)
• Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in anin vitromodel (Q39488599) (← links)
• Murine rhabdomyosarcoma is immunogenic and responsive to T‐cell‐based immunotherapy (Q39564978) (← links)
• Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy (Q39627913) (← links)
• Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma (Q45356316) (← links)
• SOCS1 prevents potentially skin-reactive cytotoxic T lymphocytes from gaining the ability to cause inflammatory lesions. (Q46987988) (← links)
• Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8 CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptides (Q50964057) (← links)
• The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up (Q58690844) (← links)
• Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals (Q80148689) (← links)
• Combining Carbon Ion Radiotherapy and Local Injection of α-Galactosylceramide–Pulsed Dendritic Cells Inhibits Lung Metastases in an In Vivo Murine Model (Q85173925) (← links)
• Adoptive T Cell Transfer to Treat Lymphangioleiomyomatosis (Q89801224) (← links)